首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test).
【24h】

Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test).

机译:对OECD筛查测试421(生殖/发育毒性筛查测试)和422(重复剂量毒性研究与生殖/发育毒性筛查测试相结合)的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

The Advisory Committee on Existing Chemicals (BUA) of the Federal Republic of Germany convened a panel with expertise in reproductive and developmental toxicology to evaluate the OECD Screening Tests 421 (Reproduction/Developmental Toxicity Screening Test) and 422 (Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test) with respect to their ability to unmask any potential toxic effects on reproduction. The original assignment for that panel was to "validate" those screening tests. However, the panel members recognized beforehand that this was actually an impossible task because of lack of a sufficient database. Only five chemicals with known reproductive toxicity had been examined following the OECD Screening Test Guidelines 421 or 422. A comparison of these test results with those of the definitive OECD Test Guidelines 414, 415, 416, or additional investigations could, therefore, only have been made with this very limited number of chemicals that had also undergone evaluation by one of the test guidelines cited. In each case biological properties relevant to reproductive toxicity were also indicated by the OECD Screening Tests 421 or 422. This communication reviews the main differences in study design of OECD Screening Test Guidelines 421 and 422 compared to those definitive test guidelines of similar study design for reproduction or developmental toxicity (especially with the one-generation study, OECD Test Guideline 415). The very limited possibilities of detecting late postnatal and postlactational manifestations are emphasized, as is the low statistical power of the OECD Screening Tests 421 and 422. Furthermore, the very limited ability to unmask teratogenicity is delineated. The outcome of screening tests was evaluated based on the results of 57 studies conducted according to the OECD Test Guideline 421 or 422. The test results were categorized according to the incidence of toxic effects on reproduction in the parent animals or their offspring and relatedto general toxic effects. Based on the ranking of these results, recommendations regarding setting rational priorities for further evaluations of existing chemicals' reproductive hazards are made. In general, the reviewer panel supports the OECD position that the screening tests are useful for initial hazard assessment and can contribute to the decision-making process on setting priorities for further test requirements. The panel also agrees with the OECD statement that the OECD Screening Tests 421 and 422 are neither an alternative to definitive tests (i.e., OECD Test Guidelines 414, 415, and 416) nor are they intended as their replacement.
机译:德意志联邦共和国现有化学品咨询委员会(BUA)召集一个在生殖和发育毒理学方面具有专业知识的专家小组,以评估OECD筛查测试421(生殖/发育毒性筛查测试)和422(重复剂量毒性联合研究)。生殖/发育毒性筛选测试),以揭示其对生殖的任何潜在毒性作用。该小组的最初任务是“验证”那些筛选测试。但是,小组成员事先意识到,由于缺乏足够的数据库,这实际上是不可能完成的任务。根据OECD筛选测试指南421或422,仅检查了五种具有已知生殖毒性的化学药品。将这些测试结果与确定的OECD测试指南414、415、416进行比较,否则只能进行其他调查。用数量非常有限的化学药品制成,这些化学药品也已通过上述测试指南之一进行了评估。在每种情况下,经合发组织筛查测试421或422也表明了与生殖毒性有关的生物学特性。本来文回顾了经合发组织筛查测试指南421和422的研究设计与与类似生殖研究设计的确定性试验指南相比的主要差异。或发育毒性(尤其是针对单代研究,OECD测试指南415)。强调了发现晚期产后和胎后表现的非常有限的可能性,以及OECD筛查测试421和422的低统计能力也得到了强调。此外,还描述了揭示致畸性的非常有限的能力。筛选测试的结果是根据根据OECD测试准则421或422进行的57项研究的结果进行评估的。测试结果根据对亲本动物或其后代繁殖的毒性影响的发生率进行分类,并与一般毒性有关效果。根据这些结果的排名,提出了有关确定合理优先级以进一步评估现有化学物质的生殖危害的建议。总的来说,审查小组支持经合组织的立场,即筛查测试对于初步危害评估很有用,并且可以为确定进一步测试要求的优先级做出决策。专家组还同意OECD的声明,即OECD筛选测试421和422既不能替代确定性测试(即OECD测试准则414、415和416),也不能用作替代。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号